Works in Cancer Chemotherapy & Pharmacology, 2007, Vol 60, Issue 6

Results: 17

Tumor specific cytotoxicity of glucosylceramide.

Published in:

Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 6, p. 767, doi. 10.1007/s00280-007-0422-y

By:

Oku, Hirosuke;
Wongtangtintharn, Sawitree;
Iwasaki, Hironori;
Inafuku, Masashi;
Shimatani, Masayuki;
Toda, Takayoshi

Publication type:

Article

O 4-benzylfolic acid inactivates O 6-alkylguanine-DNA alkyltransferase in brain tumor cell lines.

Published in:

Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 6, p. 883, doi. 10.1007/s00280-007-0435-6

By:

Johnson, Stewart P.;
Kamen, Barton A.;
Bigner, Darell D.;
Friedman, Henry S.

Publication type:

Article

A pharmacokinetic study on Z-(±)-2-(1-benzylindole-3-yl-methylene)azabicyclo[2.2.2]octane-3-ol; a novel radio-sensitization agent.

Published in:

Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 6, p. 915, doi. 10.1007/s00280-007-0425-8

By:

Al-Ghananeem, Abeer M.;
Albayati, Zaineb F.;
Malkawi, Ahmad;
Sonar, Vijayakumar N.;
Freeman, Michael L.;
Crooks, Peter A.

Publication type:

Article

Tissue distribution and depletion kinetics of bortezomib and bortezomib-related radioactivity in male rats after single and repeated intravenous injection of 14C-bortezomib.

Published in:

Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 6, p. 777, doi. 10.1007/s00280-007-0424-9

By:

Hemeryck, Alex;
Geerts, Rita;
Monbaliu, Johan;
Hassler, Stephan;
Verhaeghe, Tom;
Diels, Luc;
Verluyten, Willy;
van Beijsterveldt, Ludy;
Mamidi, Rao N. V. S.;
Janssen, Cor;
De Coster, Roland

Publication type:

Article

Preclinical pharmacokinetics and bioavailability of noscapine, a tubulin-binding anticancer agent.

Published in:

Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 6, p. 831, doi. 10.1007/s00280-007-0430-y

By:

Aneja, Ritu;
Dhiman, Neerupma;
Idnani, Jyoti;
Awasthi, Anshumali;
Arora, Sudershan K.;
Chandra, Ramesh;
Joshi, Harish C.

Publication type:

Article

Flavonoids inhibit breast cancer resistance protein-mediated drug resistance: transporter specificity and structure–activity relationship.

Published in:

Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 6, p. 789, doi. 10.1007/s00280-007-0426-7

By:

Katayama, Kazuhiro;
Masuyama, Kazuto;
Yoshioka, Sho;
Hasegawa, Hitomi;
Mitsuhashi, Junko;
Sugimoto, Yoshikazu

Publication type:

Article

Murine toxicology and pharmacokinetics of novel retinoic acid metabolism blocking agents.

Published in:

Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 6, p. 899, doi. 10.1007/s00280-007-0438-3

By:

Patel, Jyoti B.;
Khandelwal, Aakanksha;
Chopra, Pankaj;
Handratta, Venkatesh D.;
Njar, Vincent C. O.

Publication type:

Article

Assessing the therapeutic and toxicological effects of cesium chloride following administration to nude mice bearing PC-3 or LNCaP prostate cancer xenografts.

Published in:

Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 6, p. 821, doi. 10.1007/s00280-007-0429-4

By:

Low, Jonathan C.;
Wasan, Kishor W.;
Fazli, Ladan;
Eberding, Andy;
Adomat, Hans;
Guns, Emma S.

Publication type:

Article

Pharmacokinetic modulation of oral etoposide by ketoconazole in patients with advanced cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 6, p. 811, doi. 10.1007/s00280-007-0428-5

By:

Wei Peng Yong;
Desai, Apurva A.;
Innocenti, Federico;
Ramirez, Jacqueline;
Shepard, Dale;
Kobayashi, Ken;
House, Larry;
Fleming, Gini F.;
Vogelzang, Nicholas J.;
Schilsky, Richard L.;
Ratain, Mark J.

Publication type:

Article

Validation of the comet-X assay as a pharmacodynamic assay for measuring DNA cross-linking produced by the novel anticancer agent RH1 during a phase I clinical trial.

Published in:

Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 6, p. 851, doi. 10.1007/s00280-007-0432-9

By:

Danson, S.;
Ranson, M.;
Denneny, O.;
Cummings, J.;
Ward, T. H.

Publication type:

Article

Sonodynamic therapy on chemically induced mammary tumor: pharmacokinetics, tissue distribution and sonodynamically induced antitumor effect of gallium–porphyrin complex ATX-70.

Published in:

Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 6, p. 891, doi. 10.1007/s00280-007-0436-5

By:

Yumita, Nagahiko;
Okuyama, Nobuo;
Sasaki, Kazuaki;
Umemura, Shin-ichiro

Publication type:

Article

Population pharmacokinetics of a HER2 tyrosine kinase inhibitor CP-724,714 in patients with advanced malignant HER2 positive solid tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 6, p. 799, doi. 10.1007/s00280-007-0427-6

By:

Feng Guo;
Letrent, Stephen P.;
Sharma, Amarnath

Publication type:

Article

Qualification of M30 and M65 ELISAs as surrogate biomarkers of cell death: long term antigen stability in cancer patient plasma.

Published in:

Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 6, p. 921, doi. 10.1007/s00280-007-0437-4

By:

Cummings, J.;
Ranson, M.;
Butt, F.;
Moore, D.;
Dive, C.

Publication type:

Article

Effect of the Cdk-inhibitor roscovitine on mouse hematopoietic progenitors in vivo and in vitro.

Published in:

Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 6, p. 841, doi. 10.1007/s00280-007-0431-x

By:

Hairong Song;
Vita, Marina;
Sallam, Hatem;
Tehranchi, Ramin;
Nilsson, Christina;
Sidén, Åke;
Hassan, Zuzana

Publication type:

Article

Multicenter phase II study of weekly paclitaxel plus cisplatin combination chemotherapy in patients with advanced gastric cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 6, p. 863, doi. 10.1007/s00280-007-0433-8

By:

Jong Gwang Kim;
Sang Kyun Sohn;
Hong Suk Song;
Ki-Young Kwon;
Young Rok Do;
Kyung Hee Lee;
Myung Soo Hyun;
Hun Mo Ryoo;
Sung Hwa Bae;
Keon Uk Park;
Jin Ho Baek;
Won Sik Lee;
Joo Seop Chung;
Goon Jae Cho;
Chang-Hak Sohn;
Jung Soon Jang;
Ho Young Chung;
Wansik Yu

Publication type:

Article

A phase I study of bi-weekly administration of 24-h gemcitabine followed by 24-h irinotecan in patients with solid tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 6, p. 871, doi. 10.1007/s00280-007-0434-7

By:

Wasif Saif, Muhammad;
Sellers, Sandra;
Mao Li;
Wei Wang;
Cusimano, Linda;
Hui Wang;
Ruiwen Zhang

Publication type:

Article

Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model.

Published in:

Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 6, p. 907, doi. 10.1007/s00280-007-0449-0

By:

Vassileva, Vessela;
Grant, Justin;
De Souza, Raquel;
Allen, Christine;
Piquette-Miller, Micheline

Publication type:

Article

Works in Cancer Chemotherapy & Pharmacology, 2007, Vol 60, Issue 6

Tumor specific cytotoxicity of glucosylceramide.

O <sup>4</sup>-benzylfolic acid inactivates O <sup>6</sup>-alkylguanine-DNA alkyltransferase in brain tumor cell lines.

A pharmacokinetic study on Z-(±)-2-(1-benzylindole-3-yl-methylene)azabicyclo[2.2.2]octane-3-ol; a novel radio-sensitization agent.

Tissue distribution and depletion kinetics of bortezomib and bortezomib-related radioactivity in male rats after single and repeated intravenous injection of <sup>14</sup>C-bortezomib.

Preclinical pharmacokinetics and bioavailability of noscapine, a tubulin-binding anticancer agent.

Flavonoids inhibit breast cancer resistance protein-mediated drug resistance: transporter specificity and structure–activity relationship.

Murine toxicology and pharmacokinetics of novel retinoic acid metabolism blocking agents.

Assessing the therapeutic and toxicological effects of cesium chloride following administration to nude mice bearing PC-3 or LNCaP prostate cancer xenografts.

Pharmacokinetic modulation of oral etoposide by ketoconazole in patients with advanced cancer.

Validation of the comet-X assay as a pharmacodynamic assay for measuring DNA cross-linking produced by the novel anticancer agent RH1 during a phase I clinical trial.

Sonodynamic therapy on chemically induced mammary tumor: pharmacokinetics, tissue distribution and sonodynamically induced antitumor effect of gallium–porphyrin complex ATX-70.

Population pharmacokinetics of a HER2 tyrosine kinase inhibitor CP-724,714 in patients with advanced malignant HER2 positive solid tumors.

Qualification of M30 and M65 ELISAs as surrogate biomarkers of cell death: long term antigen stability in cancer patient plasma.

Effect of the Cdk-inhibitor roscovitine on mouse hematopoietic progenitors in vivo and in vitro.

Multicenter phase II study of weekly paclitaxel plus cisplatin combination chemotherapy in patients with advanced gastric cancer.

A phase I study of bi-weekly administration of 24-h gemcitabine followed by 24-h irinotecan in patients with solid tumors.

Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model.